StockData
Evaxion A/S logo

Evaxion A/S (EVAX) stock

EVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 2/30
$2.78+0.01 (+0.36%)

Close on Nov 17, 2026Market cap $23.19MP/E –Yield –

Evaxion A/S total assets

Total assets on the balance sheet at the end of each period.

Evaxion A/S's total assets was $19.38M at Jun 30, 2026. For fiscal 2025 it was $28.41M, up 127.5% from the year before. The highest annual figure on record is $40.16M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$28.41M+127.5%
FY2024Dec 31, 2024$12.49M-3.1%
FY2023Dec 31, 2023$12.89M-41.5%
FY2022Dec 31, 2022$22.03M-45.2%
FY2021Dec 31, 2021$40.16M+235.7%
FY2020Dec 31, 2020$11.97M+7.9%
FY2019Dec 31, 2019$11.08M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$19.38M+27.2%
Q4 FY2025Dec 31, 2025$28.41M+120.4%
Q2 FY2025Jun 30, 2025$22.45M+34.0%
Q4 FY2024Dec 31, 2024$12.49M-43.3%
Q2 FY2024Jun 30, 2024$15.23M-55.2%
Q4 FY2023Dec 31, 2023$12.89M-68.6%
Q2 FY2023Jun 30, 2023$16.75M-58.3%
Q4 FY2022Dec 31, 2022$22.03M-8.7%
Q2 FY2022Jun 30, 2022$34.00M+22.9%
Q1 FY2022Mar 31, 2022$41.08M+17.6%
Q4 FY2021Dec 31, 2021$40.16M+235.7%
Q3 FY2021Sep 30, 2021$24.12M+117.6%
Q2 FY2021Jun 30, 2021$27.66M–
Q1 FY2021Mar 31, 2021$34.92M–
Q4 FY2020Dec 31, 2020$11.97M–
Q4 FY2019Dec 31, 2019$11.08M–

More Evaxion A/S figures

See a number that looks wrong?